-
PhRMA Welcomes Genentech and Gilead Sciences to Association
americanpharmaceuticalreview
January 21, 2019
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced Genentech, a member of the Roche Group, and Gilead Sciences have joined the association as members....
-
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
-
Yisheng receives approval for rabies vaccine clinical study
biospectrum
October 11, 2018
The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore.
-
Athenex announces joint venture with Xiangxue Life Sciences
biospectrumasia
July 04, 2018
Apart from this, Athenex has also announced in-licensing of worldwide rights to a pegylated genetically modified human arginase from Avalon PolyTom (HK) Limited (PolyTom)
-
CASI, Yiling Wanzhou team up to manufacture entecavir, cilostazol
biospectrumasia
June 26, 2018
The contracted manufacturing facilities have been inspected by both the U.S. Food and Drug Administration (FDA) and China FDA (CFDA).
-
Janssen acquires BeneVir Biopharm to advance immunotherapy regimens
pharmatimes
May 04, 2018
Janssen has entered into a definitive agreement to acquire BeneVir Biopharm, a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies.